Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jamie R J Inshaw

Showing results (11-20 of 13) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 13 results.
Diabetes|May 2, 2022
Circulating C-Peptide Levels in Living Children and Young People and Pancreatic β-Cell Loss in Pancreas Donors Across Type 1 Diabetes Disease DurationAlice L J Carr, Jamie R J Inshaw, Christine S Flaxman, et al.
Nature Genetics|November 3, 2019
The impact of proinflammatory cytokines on the β-cell regulatory landscape provides insights into the genetics of type 1 diabetesMireia Ramos-Rodríguez, Helena Raurell-Vila, Maikel L Colli, et al.
Nature Genetics|June 15, 2021
Fine-mapping, trans-ancestral and genomic analyses identify causal variants, cells, genes and drug targets for type 1 diabetesCatherine C Robertson, Jamie R J Inshaw, Suna Onengut-Gumuscu, et al.
Pageof 2

Showing results (11-20 of 13) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 13 results.
Diabetes|May 2, 2022
Circulating C-Peptide Levels in Living Children and Young People and Pancreatic β-Cell Loss in Pancreas Donors Across Type 1 Diabetes Disease DurationAlice L J Carr, Jamie R J Inshaw, Christine S Flaxman, et al.
Nature Genetics|November 3, 2019
The impact of proinflammatory cytokines on the β-cell regulatory landscape provides insights into the genetics of type 1 diabetesMireia Ramos-Rodríguez, Helena Raurell-Vila, Maikel L Colli, et al.
Nature Genetics|June 15, 2021
Fine-mapping, trans-ancestral and genomic analyses identify causal variants, cells, genes and drug targets for type 1 diabetesCatherine C Robertson, Jamie R J Inshaw, Suna Onengut-Gumuscu, et al.
Pageof 2